Clinical Trials in CNS

Venue: Marriott Regents Park

Location: London, United Kingdom

Event Date/Time: Nov 23, 2011 End Date/Time: Nov 24, 2011
Report as Spam


SMI is proud to present the 10th annual conference…
Clinical Trials in CNS
23rd & 24th November 2011, Marriott Hotel Regent’s Park, Central London, UK

SMi is delighted to announce its 10th annual Clinical Trials in CNS conference, bringing together leading industry experts to explore the current and future opportunities within CNS drug development.

This conference aims to cover clinical drug discovery activities, new therapeutic targets, as well as effective CNS drug development strategies and problems encountered in clinical trials, with in-depth discussions and case study presentations from the key industry players.

Focusing on a wide range of therapeutic areas such Multiple Sclerosis, Parkinson’s and Alzheimer’s, as well as analysing psychiatric disorders schizophrenia and depression, this event will be a valuable opportunity to discuss with industry leaders the current landscape in clinical CNS drug development, as well as leaning about some of the most cutting edge translational research.

Our confirmed speakers include:
• Georg Terstappen, Director and Department Head, Neuroscience Discovery, Abbott
• Florien von Raison , Head of ,Global Clinical Development Unit Parkinson’s Disease, Merck Serono
• Peter Joseph Jongen, Founding Director, MS4 Research Institute
• Sophie Dix, Senior Research Scientist, Neurodegenerative Diseases Drug Hunting Team, Lilly
• Ge Ruigt, Director Experimental Medicine Neuroscience, Merck
• Paul Thompson, Associate, Director Discovery Medicine Unit, GSK
• Hitendra Parmar, European Medical Director for Alzheimer’s Disease, Pfizer
• Chas Bountra, Chief Scientist, Structural Genomics Consortium, University of Oxford
• David Dexter, Reader in NeuroPharmacology Department of Medicine, Imperial College London

Innovation, superiority and best practice proof-of-concept in CNS clinical development
22th November 2011 Marriott Regent’s Park, London
Erik Buntinx, CEO – Managing Director, PharmaNeuroBoost
Visit to register!

Sponsorship and Exhibition Opportunities are available
To find out more, contact Alia Malick - Head of Pharmaceuticals
On tel: +44 (0)20 7827 6168 or email:

Booking Information
Alternatively contact Mohammed Saffaf on Tel: +44 (0) 20 7827 6022 or email: